INTERVIEW: Carmat picks up pace with bioprosthetic heart trial
This article was originally published in Clinica
Executive Summary
French firm Carmat has sealed clinical agreements for the first human implantations of its biocompatible artificial heart, marking a major milestone in the device’s path towards regulatory approval. The data will be used to support CE marking of the artificial heart in Europe.